The Department of Justice is appealing a federal judge's order that blocks the White House from enforcing its ban on three news outlets: MS NOW, CNN, and Politico. The judge ruled that these outlets can maintain access to the White House, citing likely First Amendment violations by the Trump administration. This appeal follows a preliminary injunction replacing an earlier temporary restraining order. The case continues as the news outlets challenge the ban legally.
The Trump administration's appeal of a federal judge's order blocking a White House ban on MS NOW, CNN, and Politico is the subject here. For readers following the media sector, here is Pluang's market snapshot as of Oct 15, 2026 01:51 WIB: out of 58 priced US media stocks, 10 rose and 46 fell. Notable movers include RUM at USD 6.04 with a -9.91% change, LUMN at USD 4.54 down 8.92%, and SNAP at USD 6.00 down 7.47%.
Jefferies has maintained a Buy rating on Big Yellow Group despite recent stock declines, citing the company's strong fundamentals including freehold properties and solid cash flows. Activist investor Ancora, holding over 4% of shares, is pushing Big ...
Fastenal reported strong Q3 2026 earnings, beating analyst expectations with EPS of $0.35 and revenue of $2.46 billion. The company saw a 20% rise in net income to $401.6 million and a 15.5% increase in revenue driven by robust manufacturing demand, ...
Remittix announced the public launch of its RTX token on November 24, 2026, marking the end of its presale phase which raised over $32 million from 40,000 participants. The project is testing its PayFi platform, which enables crypto-to-fiat and fiat-...
The global microbiology testing market is projected to grow rapidly at a compound annual growth rate (CAGR) of approximately 9% from 2026 to 2034, reaching a market size of $13.7 billion by 2034. This growth is driven by the rising prevalence of infe...
H.C. Wainwright raised its price target for Alector from $5.00 to $8.00, maintaining a Buy rating due to progress in its neurodegenerative disease pipeline. Alector develops treatments for Alzheimer's and Parkinson's using its Brain Carrier platform ...
